# Feasibility Assessment of a Medical Device for Tumour Cell Retention and Radiotherapy Sensitization in Patients With Suspected High-grade Glioma

> **NCT07725640** · NA · NOT_YET_RECRUITING · sponsor: **Batea Oncology** · enrollment: 15 (estimated)

## Conditions studied

- Glioma
- High-Grade Glioma (HGG)
- Surgical Resection

## Interventions

- **DEVICE:** GlioHook device

## Key facts

- **NCT ID:** NCT07725640
- **Lead sponsor:** Batea Oncology
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-30
- **Primary completion:** 2028-10-30
- **Final completion:** 2028-10-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07725640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07725640, "Feasibility Assessment of a Medical Device for Tumour Cell Retention and Radiotherapy Sensitization in Patients With Suspected High-grade Glioma". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07725640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*